Objective
The maintenance of the skeleton is tightly coupled with balanced bone formation and resorption processes that are mediated by osteoblasts and osteoclasts, respectively. Loss of this balance results in skeletal pathologies representing some of the most significant public health threats faced by the growing and ageing population. Tissue engineering investigates various health aspects such as drug development, fundamental research and regenerative medicine. State-of-the-art approaches are lacking to mimic one essential functional property of bone: to adapt its 3D morphology according to imposed mechanical loads. As most drugs for skeletal diseases act on this anabolic-catabolic balance, an engineered system serving as a human in vitro model for drug discovery/testing needs to be able to mimic this process. This proposal aims at combining real-time monitoring of mineralized extracellular matrix with bone tissue engineering culture standards in advanced bioreactors and will design a reliable 3D in vitro model system to mimic load induced remodeling of tissue-engineered human bone. The following particulars will be systematically addressed: i) Establishment of a co-culture of human bone-forming cells and human bone resorbing cells capable of mimicking bone remodeling; ii) Real-time monitoring platform in 3D in order to take the temporo-spatial development of the tissue into account and to allow specific adapted and controlled interventions depending on the actual environmental situation; iii) Quantitative simulation of morphological bone adaptation induced by mechanical load. The proposed research activity will have important implications in fields ranging from pharmacology and biotechnology to biomechanics and medicine. It will result in a ground-breaking platform that could be applied to screen initial bone drug effects and will improve our fundamental understanding of structure-function relationships in normal and diseased bone conditions.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy drug discovery
- medical and health sciences health sciences public health epidemiology epidemics prevention
- medical and health sciences medical biotechnology tissue engineering
- medical and health sciences basic medicine pathology
- natural sciences biological sciences biophysics
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
ERC-2013-StG
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Host institution
5612 AE Eindhoven
Netherlands
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.